Current assets
EX-10.2 3 f23671exv10w2.htm EXHIBIT 10.2 exv10w2
Exhibit 10.2
ADDENDUM B
SIPEX CORPORATION
DISTRIBUTOR AGREEMENT
SIPEX CORPORATION
DISTRIBUTOR AGREEMENT
As per the provisions of the Distributor Agreement between SIPEX CORPORATION and FUTURE ELECTRONICS INC. dated July 1,1993 the Authorized Distributor Agreement between the above captioned parties is hereby amended to include the following:
This amendment authorizes the following locations of Future Electronics to sell products manufactured by SIPEX CORPORATION.
Worldwide
(Schedule of location attached)
(Schedule of location attached)
All other terms and conditions to the Distributor Agreement dated July 1, 1993, between Future Electronics and Sipex Corporation shall remain unchanged.
FUTURE ELECTRONICS | SIPEX CORPORATION | |||||||
BY: | /s/ Sam Abrams | BY: | /s/ Walid Maghribi | |||||
Sam Abrams | Walid Maghribi | |||||||
(Printed Name) | (Printed Name) | |||||||
TITLE: Executive Vice President | TITLE: President & CEO | |||||||
DATE: August 26, 2003 | DATE: 8|29|03 |
SCHEDULE A
WORLDWIDE
America
City | State/Province | Country | ||
[] | [] | Canada | ||
[] | [] | Canada | ||
[] | [] | Canada | ||
[] | [] | Canada | ||
[] | [] | Canada | ||
[] | [] | Canada | ||
[] | [] | Canada | ||
[] | [] | Canada | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. |
INITIAL: | /s/ SA | /s/ Walid Maghribi | ||||
[] Information redacted pursuant to a confidential treatment request by Sipex Corporation under 17 CFR §§ 200.80(b)(4) and 240.24b-2 and submitted separately with the Securities and Exchange Commission.
13
SCHEDULE A
WORLDWIDE
America
City | State/Province | Country | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | U.S.A. | ||
[] | [] | |||
[] | [] | |||
[] | [] | |||
[] | [] | |||
[] | [] | |||
[] | [] | |||
[] | [] |
INITIAL: | /s/ SA | /s/ Walid Maghribi | ||||
[] Information redacted pursuant to a confidential treatment request by Sipex Corporation under 17 CFR §§ 200.80(b)(4) and 240.24b-2 and submitted separately with the Securities and Exchange Commission.
14
SCHEDULE A
WORLDWIDE
America
Europe
City | Country | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] |
INITIAL: | /s/ SA | /s/ Walid Maghribi | ||||
[] Information redacted pursuant to a confidential treatment request by Sipex Corporation under 17 CFR §§ 200.80(b)(4) and 240.24b-2 and submitted separately with the Securities and Exchange Commission.
15
SCHEDULE A
WORLDWIDE
America
Asia
City | Country | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] | |
[] | [] |
INITIAL: | /s/ SA | /s/ Walid Maghribi | ||||
[] Information redacted pursuant to a confidential treatment request by Sipex Corporation under 17 CFR §§ 200.80(b)(4) and 240.24b-2 and submitted separately with the Securities and Exchange Commission.
16